you can answer your own question on that one.
Think about it. Will Vyleesi which is already pushed back to June (or longer) have any time to help keep the lights on? Especially with our brilliant new strategy of pushing all efforts toward Intrarosa?
After the not so wonderful performance of our managed care department, how secure are you that the coverage will be there for vyleesi when it is essentially considered a recreational drug?
Try selling that drug quickly on a cash pay basis. Do you not smell the next lay off yet?
There are still overlaps of too many SAR’s in most states, geography lines that were drawn with only the first lay-off in mind, stock that has sunk since the investors pulled out and inexperienced RSD’s trying to control the craziness. Add to it a VP of sales and his band of monkey Area Directors that walk around bragging about giving “high five’s”” in the hallways of corporate as Rome burns around them.
Study material starts today for Intrarosa and Makena. I suggest you all get your resumes up to date on your time off. This company is positioning to sell.